Skip to main content
. 2015 Sep 21;34(6):581–587. doi: 10.1200/JCO.2015.61.8413

Fig A1.

Fig A1.

NCCTG N9831 clinical trial schema. Doxorubicin (A) 60 mg/m2; cyclophosphamide (C) 600 mg/m2; paclitaxel 80 mg/m2; trastuzumab 4 mg/kg loading dose followed by 2 mg/kg weekly (qw). Eval, evaluation; LVEF, left ventricular ejection fraction; q3w, every 3 weeks.